Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan F List

Showing results (21-30 of 212) with videos related to

Pageof 22
Sort By:
Mayo Clinic Proceedings|May 13, 2005
Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversityDavid P Steensma, Alan F List
Journal of the National Comprehensive Cancer Network : JNCCN|January 13, 2006
Developmental therapeutics for myelodysplastic syndromesAung Naing, Lubomir Sokol, Alan F List
Clinical Advances in Hematology & Oncology : H&O|June 14, 2014
The clinical management of chronic myelomonocytic leukemiaEric Padron, Rami Komrokji, Alan F List
Expert Review of Hematology|February 17, 2011
Biology and treatment of the 5q- syndromeEric Padron, Rami Komrokji, Alan F List
Clinical Lymphoma, Myeloma & Leukemia|August 12, 2018
SOHO State of the Art and Next Questions: Management of Myelodysplastic Syndromes With Deletion 5qChetasi Talati, David Sallman, Alan F List
Current Opinion in Hematology|May 27, 2009
Advancements in the molecular pathogenesis of myelodysplastic syndromePearlie K Epling-Burnette, Alan F List
Current Treatment Options in Oncology|October 4, 2011
The 5q- syndrome: biology and treatmentEric Padron, Rami Komrokji, Alan F List
Cancer Treatment and Research|November 6, 2010
The hematopoietic growth factors in the myelodysplastic syndromesJose Ortega, Rami Komrokji, Alan F List
Blood|October 7, 2016
When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemiaMarkus Ball, Alan F List, Eric Padron
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Proceedings of the Third Annual Meeting of the Society of Hematologic OncologyAlan F List, Hagop Kantarjian, Emil J Freireich
Pageof 22

Showing results (21-30 of 212) with videos related to

Sort By:
Pageof 22
Mayo Clinic Proceedings|May 13, 2005
Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversityDavid P Steensma, Alan F List
Journal of the National Comprehensive Cancer Network : JNCCN|January 13, 2006
Developmental therapeutics for myelodysplastic syndromesAung Naing, Lubomir Sokol, Alan F List
Clinical Advances in Hematology & Oncology : H&O|June 14, 2014
The clinical management of chronic myelomonocytic leukemiaEric Padron, Rami Komrokji, Alan F List
Expert Review of Hematology|February 17, 2011
Biology and treatment of the 5q- syndromeEric Padron, Rami Komrokji, Alan F List
Clinical Lymphoma, Myeloma & Leukemia|August 12, 2018
SOHO State of the Art and Next Questions: Management of Myelodysplastic Syndromes With Deletion 5qChetasi Talati, David Sallman, Alan F List
Current Opinion in Hematology|May 27, 2009
Advancements in the molecular pathogenesis of myelodysplastic syndromePearlie K Epling-Burnette, Alan F List
Current Treatment Options in Oncology|October 4, 2011
The 5q- syndrome: biology and treatmentEric Padron, Rami Komrokji, Alan F List
Cancer Treatment and Research|November 6, 2010
The hematopoietic growth factors in the myelodysplastic syndromesJose Ortega, Rami Komrokji, Alan F List
Blood|October 7, 2016
When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemiaMarkus Ball, Alan F List, Eric Padron
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Proceedings of the Third Annual Meeting of the Society of Hematologic OncologyAlan F List, Hagop Kantarjian, Emil J Freireich
Pageof 22